Needle-Free Drug Injection Systems Market Growth Analysis

Needle-Free Drug Injection Systems Market Growth Analysis

Needle-Free Drug Injection Systems Market Growth Analysis
Report code - SR1451 Delivery - 2 Weeks
Needle-Free Drug Injection Systems Market Growth, Trends, Dynamics & Market Insights: See more...

Market Insights

The Needle-Free Drug Injection Systems Market was valued at US$ 22.67 billion in 2021 and is projected to reach US$ 59.72 billion by 2028, registering a CAGR of 14.79% during the forecast period.

What is a needle-free injection system?

A needle-free injection system can be defined as a technique which a wide range of drug delivery systems such as jet-based needle-free injectors, spring-based needle-free injectors, laser-powered needle-free injectors, vibration-based needle-free injectors. In these systems, drugs are delivered through the skin using forces like pressure by gas, electrophoresis, or shock waves. It does not require the usage of a hypodermic needle.

Needle-Free Drug Injection Systems Market Features

Market Size in 2028

USD 59.72 billion

Market Size in 2021

USD 22.67 billion

Market Growth (2022-2028)

CAGR of 14.79%

Base Year of Study

2021

Trend Period

2017-2020

Forecast Period

2022-2028

Segments Covered

By Type (Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors)

By Application (Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical, and Biotechnology companies, Others)

By Region (North America, Europe, Asia-Pacific, and the Rest of the World)

Dominant Region

The North American market accounted for the largest market share in 2021.

Key Players

Key players operating in the Needle-Free Drug Injection Systems market are-

  • Antares Pharma, Inc. (US)
  • Endo International plc (US)
  • PharmaJet (U.S)
  • Bioject Medical Technologies Inc. (U.S)
  • Medical International Technology, Inc. (U.S)
  • INJEX Pharma AG (Germany)
  • National Medical Products Inc. (US)
  • Valeritas, Inc. (US)
  • European Pharma Group (Netherland)
  • PenJet Corporation (U.S)
  • Crossject SA (France)

Market Dynamics

The growth of the needle-free drug injection systems market is primarily driven by the increasing prevalence of chronic diseases due to changing lifestyles and unhealthy diets. Expanding geriatric populace is another factor likely to drive the growth of needle-free drug injection systems at a significant rate during the review period. In addition to this, surging demand for advanced drug delivery systems is likely to create lucrative opportunities for the players operating in the global market in the coming years.

Wish to get a free sample? Register Here

Segment Analysis

Application Type

The market has been bifurcated into hospitals and clinics, home care settings, research laboratories, pharmaceutical, and biotechnology companies, and others. Under these, the hospitals & clinics segment accounted for the largest market share in 2021 and is projected to register significant growth during the review period. The segment growth can be attributed to the presence of established infrastructure and skilled healthcare professionals.

Regional Analysis

North America accounted for the largest market share in 2021 and is projected to grow at a significant CAGR during the assessment period. The segment growth is primarily attributed to the high demand for advanced drug delivery systems coupled with the presence of key market players such as Antares Pharma, Inc. (US) and Endo International plc (US). The market growth in the Asia-Pacific region is expected to be driven by increasing spending on healthcare.

Know which region offers the best growth opportunities, Register Here

Market Segmentation

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The market is segmented into the following categories-

By Type

  • Based Needle-Free Injectors
  • Spring-Based Needle-Free Injectors
  • Laser-Powered Needle-Free Injectors
  • Vibration-Based Needle-Free Injectors

By Application Type

  • Hospitals and Clinics
  • Homecare Settings
  • Research Laboratories
  • Pharmaceutical
  • Biotechnology companies
  • Others

By Region

  • North America
  • Asia-Pacific
  • Europe
  • Rest of the World

COVID-19 Impact

The outbreak of the COVID-19 virus posed significant challenges to the growth of the healthcare industry significantly. Stringent lockdown measures and restricted movement of people affected the product demand and supply for a short period.

Critical Questions Answered in the Report

  • What are the key trends in the market?
  • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
  • What is the impact of COVID-19 on the market?
  • What are the key strategies adopted by the major vendors to lead in the market?
  • What is the market share of the top vendors?

Target Audience

Here is the list of the group of customers that the needle-free drug injection systems market hopes to have the greatest opportunity to convert-

  • Distributors
  • Suppliers
  • Manufacturers
  • Logistics organizations
  • Government bodies

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

  • Overview, industry life cycle analysis, supply chain analysis.
  • Environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
  • Trend and forecast analysis.
  • Segment trend and forecast.
  • Competitive landscape and dynamics: Market share, Product portfolio, New Product Launches, etc.
  • Attractive market segments and associated growth opportunities.
  • Emerging trends.
  • Strategic growth opportunities for the existing and new players.
  • Key success factors.

Report – Features

Market Segmentation

3

Regions Covered

4

Countries/Sub-Regions Covered

14

No. of Figures & Tables

>150

Company Profiles

11

Research Methodology

This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s market realities and future market possibilities for the forecast period of 2022 to 2028.

The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market.

The vital data/information provided in the report can play a crucial role for the market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. 

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. 

We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Report Customization

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

  • Detailed profiling of additional market players (up to three players)
  • SWOT analysis of key players (up to three players)

Competitive Benchmarking

  • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

Frequently Asked Questions (FAQs)

A needle-free injection system can be defined as a technique which a wide range of drug delivery systems such as jet-based needle-free injectors, spring-based needle-free injectors, laser-powered needle-free injectors, vibration-based needle-free injectors. In these systems, drugs are delivered through the skin using forces like pressure by gas, electrophoresis, or shock waves. It does not require the usage of a hypodermic needle.

The needle-free injection systems market are projected to grow from USD 22.67 billion in 2021 to USD 59.72 billion by 2028.

The needle-free injection systems market are expected to witness an impressive growth of 14.79% CAGR in the coming years.

Antares Pharma, Inc. (US), Endo International plc (US), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (US), Valeritas, Inc. (US), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).

North America accounted for the largest market share in 2021.

The hospitals & clinics segment accounted for the largest market share in 2021.

By Type (Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors), Application (Hospitals and Clinics, Homecare Settings, Research Laboratories, Pharmaceutical, and Biotechnology companies, Other), and Region - COVID-19 Impact Analysis and Forecast to 2028.